Gingival Inflammation, Dental Plaque and Gingival Bleeding. Chronic periodontitis
Conditions
Interventions
Intervention 1: In control group, one lozenge with the commercial name of Mentazine 500, made in Iran, with peppermint extract of %0.25, anise extract of %0.25 and liquorice extract of %5 was used as
Treatment - Drugs
In control group, one lozenge with the commercial name of Mentazine 500, made in Iran, with peppermint extract of %0.25, anise extract of %0.25 and liquorice extract of %5 was used as a placebo after
In case group, a probiotic lozenge with the commercial name of Evoraplus, made in America, was used with 600 Million CFU Probiora3® as its main ingredient. Patients took one lozenge for 14 nights afte
Sponsors
Vice chancellor for research, Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
23 Years to 33 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: mild to average chronic gingivitis with a mean gingival index of 1 to 2 millimeters without losing adherence and without periodontal pocket; lack of any systemic illness such as coronary and respiratory diseases, hemorrhagic problems, liver or kidney issues; no antibiotic consumption 3 months prior to the test; not being pregnant or breast-feeding; lack of physical or mental disablement with interfering effects on good oral hygiene; being a non-smoker; having not used mouthwash 3 months prior to the test; no drug consumption with interfering effects; lack of orthodontic appliances; non mouth breathers; absence of severe dental crowding
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dental plaque. Timepoint: One week before prophylaxis and at the end of two weeks. Method of measurement: Based on percentage and by using O'leary index (1972).;Gingival bleeding. Timepoint: One week before prophylaxis and at the end of two weeks. Method of measurement: Based on bleeding on probing and by using Ainamo and Bay (1975).;Gingival inflammation. Timepoint: One week before prophylaxis and at the end of two weeks. Method of measurement: Based on scores 0,1,2,3 and by using silness-loe (1963). | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in taste. Timepoint: One week after prophylaxis and at the end of two weeks. Method of measurement: Clinical observation.;Changes in gustatory system. Timepoint: One week after prophylaxis and at the end of two weeks. Method of measurement: Clinical observation.;Irritation of the mucous. Timepoint: One week after prophylaxis and at the end of two weeks. Method of measurement: Clinical observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboubeh Asgharniay Hassan Kiadeh
Guilan University of Medical Sciences
Outcome results
None listed